2026 Q2 Portfolio Activity
In 2026 Q2, PSP Research LLC maintained a portfolio of 90 distinct positions. The most significant new addition was ASCENDIS PHARMA A/S, now representing 0.21% of the total fund value. They heavily accumulated shares in SPDR SERIES TRUST, increasing the position by 100.1%. Conversely, PSP Research LLC completely exited their position in SERA PROGNOSTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
90
Quarter
2026 Q2
Top Holding
XBI (48.0%)
Top 10 Concentration
88.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 90
PSP Research LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
XBI
SPDR SERIES TRU...
|
Unknown | 48.01% | 25.75% |
#1
1
Prev: #2
|
9.0 |
—
|
285,100 | 100.1% |
P
S
|
570,000 | $90,202,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
SGOV
ISHARES TR
|
ETF | 37.51% | 49.86% |
#2
1
Prev: #1
|
6.5 |
—
|
no change | no change |
P
S
|
700,000 | $70,469,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 0.33% | 0.37% |
#3
6
Prev: #9
|
2.1 |
—
|
no change | no change |
P
S
|
11,000 | $616,770 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.32% | 0.31% |
#4
33
Prev: #37
|
1.1 |
—
|
-3,700 | -12.9% |
P
S
|
25,000 | $606,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
INCY
INCYTE CORP
|
Healthcare | 0.32% | 0.35% |
#5
12
Prev: #17
|
1.6 |
—
|
no change | no change |
P
S
|
5,300 | $600,808 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.32% | 0.33% |
#6
20
Prev: #26
|
1.1 |
—
|
no change | no change |
P
S
|
641 | $594,701 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.31% | 0.36% |
#7
6
Prev: #13
|
1.1 |
—
|
no change | no change |
P
S
|
8,000 | $585,120 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 0.31% | 0.31% |
#8
32
Prev: #40
|
1.1 |
—
|
no change | no change |
P
S
|
14,000 | $583,380 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.30% | 0.33% |
#9
21
Prev: #30
|
0.1 |
—
|
-5,100 | -23.1% |
P
S
|
17,000 | $567,630 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.30% | 0.25% |
#10
44
Prev: #54
|
1.1 |
—
|
no change | no change |
P
S
|
30,000 | $559,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.30% | 0.33% |
#11
22
Prev: #33
|
0.6 |
—
|
-5,000 | -17.9% |
P
S
|
23,000 | $556,600 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 0.29% | 0.31% |
#12
31
Prev: #43
|
0.1 |
—
|
-3,000 | -23.1% |
P
S
|
10,000 | $549,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
HALO
HALOZYME THERAP...
|
Healthcare | 0.29% | 0.37% |
#13
2
Prev: #11
|
0.6 |
—
|
-1,026 | -12.8% |
P
S
|
7,000 | $547,890 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.29% | 0.36% |
#14
Prev: #14
|
1.1 |
—
|
no change | no change |
P
S
|
6,800 | $539,172 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.28% | 0.40% |
#15
8
Prev: #7
|
0.1 |
—
|
-5,000 | -25.0% |
P
S
|
15,000 | $518,700 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.27% | 0.33% |
#16
13
Prev: #29
|
1.1 |
—
|
no change | no change |
P
S
|
19,700 | $516,534 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
AUPH
AURINIA PHARMAC...
|
Healthcare | 0.27% | 0.31% |
#17
21
Prev: #38
|
1.1 |
—
|
no change | no change |
P
S
|
30,000 | $509,100 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.27% | 0.36% |
#18
2
Prev: #16
|
0.1 |
—
|
-848 | -22.0% |
P
S
|
3,000 | $505,605 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.27% | 0.34% |
#19
6
Prev: #25
|
0.1 |
—
|
-6,200 | -32.3% |
P
S
|
13,000 | $500,890 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.27% | 0.31% |
#20
19
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
19,766 | $500,080 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 0.26% | 0.29% |
#21
25
Prev: #46
|
1.1 |
—
|
no change | no change |
P
S
|
6,000 | $489,420 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.26% | 0.29% |
#22
23
Prev: #45
|
1.1 |
—
|
no change | no change |
P
S
|
13,000 | $483,730 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.26% | 0.32% |
#23
11
Prev: #34
|
1.1 |
—
|
no change | no change |
P
S
|
15,141 | $480,727 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.25% | 0.47% |
#24
20
Prev: #4
|
0.1 |
—
|
-24,800 | -71.3% |
P
S
|
10,000 | $470,400 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.25% | 0.33% |
#25
7
Prev: #32
|
1.1 |
—
|
no change | no change |
P
S
|
12,000 | $464,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.24% | 0.37% |
#26
16
Prev: #10
|
0.1 |
—
|
-2,300 | -36.5% |
P
S
|
4,000 | $458,680 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.24% | 0.26% |
#27
26
Prev: #53
|
1.1 |
—
|
no change | no change |
P
S
|
20,000 | $444,200 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.23% | 0.34% |
#28
8
Prev: #20
|
1.1 |
—
|
no change | no change |
P
S
|
1,465 | $441,009 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.23% | 0.35% |
#29
11
Prev: #18
|
1.1 |
—
|
no change | no change |
P
S
|
7,000 | $440,580 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.23% | 0.33% |
#30
3
Prev: #27
|
1.1 |
—
|
no change | no change |
P
S
|
20,000 | $437,200 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
EXEL
EXELIXIS INC
|
Healthcare | 0.23% | 0.36% |
#31
19
Prev: #12
|
0.1 |
—
|
-3,948 | -33.0% |
P
S
|
8,000 | $435,280 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.22% | 0.28% |
#32
17
Prev: #49
|
1.1 |
—
|
no change | no change |
P
S
|
11,000 | $411,620 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 0.22% | 0.34% |
#33
10
Prev: #23
|
0.1 |
—
|
-3,000 | -20.0% |
P
S
|
12,000 | $406,680 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 0.21% | — |
#34
Prev: #—
|
3.6 |
—
|
1,500 | — |
NEW
|
1,500 | $400,080 | — | 13F Filing | 2026-06-30 | 2026-07-09 | ||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 0.21% | — |
#35
Prev: #—
|
3.6 |
—
|
5,000 | — |
NEW
|
5,000 | $398,650 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.21% | 0.28% |
#36
15
Prev: #51
|
1.1 |
—
|
no change | no change |
P
S
|
12,000 | $392,640 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.21% | 0.35% |
#37
18
Prev: #19
|
0.1 |
—
|
-5,000 | -33.3% |
P
S
|
10,000 | $390,100 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.20% | 0.31% |
#38
3
Prev: #41
|
0.6 |
—
|
-2,000 | -10.0% |
P
S
|
18,000 | $381,420 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.20% | 0.22% |
#39
17
Prev: #56
|
1.1 |
—
|
no change | no change |
P
S
|
3,000 | $367,740 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.19% | 0.28% |
#40
8
Prev: #48
|
0.1 |
—
|
-4,283 | -30.0% |
P
S
|
10,000 | $364,100 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.19% | 0.19% |
#41
20
Prev: #61
|
1.1 |
—
|
no change | no change |
P
S
|
7,000 | $355,250 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 0.19% | 0.18% |
#42
20
Prev: #62
|
0.1 |
—
|
-1,159 | -22.5% |
P
S
|
4,000 | $355,120 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.18% | 0.24% |
#43
12
Prev: #55
|
0.1 |
—
|
-6,900 | -25.7% |
P
S
|
20,000 | $338,400 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.17% | 0.22% |
#44
13
Prev: #57
|
1.1 |
—
|
no change | no change |
P
S
|
600 | $322,170 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 0.17% | 0.31% |
#45
3
Prev: #42
|
0.1 |
—
|
-4,000 | -44.4% |
P
S
|
5,000 | $319,750 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.17% | 0.15% |
#46
23
Prev: #69
|
1.1 |
—
|
no change | no change |
P
S
|
6,000 | $314,370 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.17% | 0.21% |
#47
12
Prev: #59
|
0.1 |
—
|
-4,400 | -30.6% |
P
S
|
10,000 | $312,600 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.16% | 0.34% |
#48
24
Prev: #24
|
0.1 |
—
|
-20,000 | -25.0% |
P
S
|
60,000 | $306,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.16% | 0.28% |
#49
2
Prev: #47
|
0.1 |
—
|
-3,000 | -30.0% |
P
S
|
7,000 | $300,370 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 0.16% | 0.33% |
#50
19
Prev: #31
|
0.1 |
—
|
-2,500 | -50.0% |
P
S
|
2,500 | $292,675 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-09 |
Showing 1-50 of 90 holdings